BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17673701)

  • 1. USF1 contributes to high serum lipid levels in Dutch FCHL families and U.S. whites with coronary artery disease.
    Lee JC; Weissglas-Volkov D; Kyttälä M; Sinsheimer JS; Jokiaho A; de Bruin TW; Lusis AJ; Brennan ML; van Greevenbroek MM; van der Kallen CJ; Hazen SL; Pajukanta P
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2222-7. PubMed ID: 17673701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia.
    Plaisier CL; Horvath S; Huertas-Vazquez A; Cruz-Bautista I; Herrera MF; Tusie-Luna T; Aguilar-Salinas C; Pajukanta P
    PLoS Genet; 2009 Sep; 5(9):e1000642. PubMed ID: 19750004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USF1 gene variants, cardiovascular risk, and mortality in European Americans: analysis of two US cohort studies.
    Reiner AP; Carlson CS; Jenny NS; Durda JP; Siscovick DS; Nickerson DA; Tracy RP
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2736-42. PubMed ID: 17885212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides.
    Coon H; Xin Y; Hopkins PN; Cawthon RM; Hasstedt SJ; Hunt SC
    Hum Genet; 2005 Sep; 117(5):444-51. PubMed ID: 15959806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population.
    Di Taranto MD; Staiano A; D'Agostino MN; D'Angelo A; Bloise E; Morgante A; Marotta G; Gentile M; Rubba P; Fortunato G
    Mol Cell Probes; 2015 Feb; 29(1):19-24. PubMed ID: 25308402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1.
    Huertas-Vazquez A; Aguilar-Salinas C; Lusis AJ; Cantor RM; Canizales-Quinteros S; Lee JC; Mariana-Nuñez L; Riba-Ramirez RM; Jokiaho A; Tusie-Luna T; Pajukanta P
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1985-91. PubMed ID: 15976322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
    Pajukanta P; Lilja HE; Sinsheimer JS; Cantor RM; Lusis AJ; Gentile M; Duan XJ; Soro-Paavonen A; Naukkarinen J; Saarela J; Laakso M; Ehnholm C; Taskinen MR; Peltonen L
    Nat Genet; 2004 Apr; 36(4):371-6. PubMed ID: 14991056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation within the gene encoding the upstream stimulatory factor 1 does not influence susceptibility to type 2 diabetes in samples from populations with replicated evidence of linkage to chromosome 1q.
    Zeggini E; Damcott CM; Hanson RL; Karim MA; Rayner NW; Groves CJ; Baier LJ; Hale TC; Hattersley AT; Hitman GA; Hunt SE; Knowler WC; Mitchell BD; Ng MC; O'Connell JR; Pollin TI; Vaxillaire M; Walker M; Wang X; Whittaker P; Xiang K; Jia W; Chan JC; Froguel P; Deloukas P; Shuldiner AR; Elbein SC; McCarthy MI;
    Diabetes; 2006 Sep; 55(9):2541-8. PubMed ID: 16936202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of upstream stimulatory factor 1 gene variant in familial combined hyperlipidemia and related disorders.
    Auer S; Hahne P; Soyal SM; Felder T; Miller K; Paulmichl M; Krempler F; Oberkofler H; Patsch W
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1535-44. PubMed ID: 22460558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis.
    Laurila PP; Naukkarinen J; Kristiansson K; Ripatti S; Kauttu T; Silander K; Salomaa V; Perola M; Karhunen PJ; Barter PJ; Ehnholm C; Peltonen L
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):346-52. PubMed ID: 19910639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.
    Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
    J Clin Lipidol; 2016; 10(6):1329-1337.e3. PubMed ID: 27919349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upstream transcription factor 1 (USF1) in risk of type 2 diabetes: association study in 2000 Dutch Caucasians.
    Meex SJ; van Vliet-Ostaptchouk JV; van der Kallen CJ; van Greevenbroek MM; Schalkwijk CG; Feskens EJ; Blaak EE; Wijmenga C; Hofker MH; Stehouwer CD; de Bruin TW
    Mol Genet Metab; 2008 Jul; 94(3):352-5. PubMed ID: 18445538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pro12A1a substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia.
    Pihlajamäki J; Miettinen R; Valve R; Karjalainen L; Mykkänen L; Kuusisto J; Deeb S; Auwerx J; Laakso M
    Atherosclerosis; 2000 Aug; 151(2):567-74. PubMed ID: 10924736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the complex genetics of familial combined hyperlipidemia.
    Suviolahti E; Lilja HE; Pajukanta P
    Ann Med; 2006; 38(5):337-51. PubMed ID: 16938803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of upstream stimulatory factor 1 in Dutch patients with familial combined hyperlipidemia.
    van der Vleuten GM; Isaacs A; Hijmans A; van Duijn CM; Stalenhoef AF; de Graaf J
    J Lipid Res; 2007 Jan; 48(1):193-200. PubMed ID: 17065663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemia.
    Huertas-Vazquez A; Plaisier CL; Geng R; Haas BE; Lee J; Greevenbroek MM; van der Kallen C; de Bruin TW; Taskinen MR; Alagramam KN; Pajukanta P
    Hum Genet; 2010 Jan; 127(1):83-9. PubMed ID: 19816713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels.
    Pajukanta P; Terwilliger JD; Perola M; Hiekkalinna T; Nuotio I; Ellonen P; Parkkonen M; Hartiala J; Ylitalo K; Pihlajamäki J; Porkka K; Laakso M; Viikari J; Ehnholm C; Taskinen MR; Peltonen L
    Am J Hum Genet; 1999 May; 64(5):1453-63. PubMed ID: 10205279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia.
    Hoffer MJ; Bredie SJ; Boomsma DI; Reymer PW; Kastelein JJ; de Knijff P; Demacker PN; Stalenhoef AF; Havekes LM; Frants RR
    Atherosclerosis; 1996 Jan; 119(2):159-67. PubMed ID: 8808493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carotid artery intima-media thickness in Finnish families with familial combined hyperlipidemia.
    Ylitalo K; Syvänne M; Salonen R; Nuotio I; Taskinen MR; Salonen JT
    Atherosclerosis; 2002 May; 162(1):171-8. PubMed ID: 11947911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease.
    Vikulova DN; Trinder M; Mancini GBJ; Pimstone SN; Brunham LR
    Can J Cardiol; 2021 Nov; 37(11):1733-1742. PubMed ID: 34455025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.